The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network
The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year. Descriptive statistical approaches will be used to process the data. The aim is to evaluate the development rate of severe clinical forms of infection in patients with SARS-Cov-2 and the possible association with tumour characteristics and treatment. In addition, the results of serological tests can be compared with the outcome of the diagnostic swabs and the clinical evolution of the infection in order to obtain more information regarding the significance of specific antibody development.
Study Type
OBSERVATIONAL
Enrollment
761
istituto Oncologico Veneto -UOSD Melanoma
Padova, PD, Italy
Aulss1 Dolomiti
Belluno, Italy
Istituto Oncologico Veneto -UOC Oncologia 1
Padova, Italy
The rate of SAR-COV2 infection development in association with tumor characteristics.
Time frame: through study completion, an average of 18 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.